Found: 2
Select item for more details and to access through your institution.
Benefit of adjuvant chemotherapy with or without trastuzumab in pT1ab node-negative human epidermal growth factor receptor 2-positive breast carcinomas: results of a national multi-institutional study.
- Published in:
- Breast Cancer Research & Treatment, 2017, v. 162, n. 2, p. 307, doi. 10.1007/s10549-017-4136-5
- By:
- Publication type:
- Article
Neoadjuvant chemotherapy for unresectable ovarian carcinoma.
- Published in:
- Cancer (0008543X), 2001, v. 91, n. 12, p. 2329, doi. 10.1002/1097-0142(20010615)91:12<2329::AID-CNCR1265>3.0.CO;2-U
- By:
- Publication type:
- Article